These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17401268)

  • 21. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
    Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
    Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pruritus associated with cholestasis].
    Terán A; Fábrega E; Pons-Romero F
    Gastroenterol Hepatol; 2010 Apr; 33(4):313-22. PubMed ID: 19836105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.
    Prince MI; Burt AD; Jones DE
    Gut; 2002 Mar; 50(3):436-9. PubMed ID: 11839728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
    Beuers U; Wolters F; Oude Elferink RPJ
    Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in pathogenesis and treatment of pruritus.
    Bolier R; Oude Elferink RP; Beuers U
    Clin Liver Dis; 2013 May; 17(2):319-29. PubMed ID: 23540505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
    Tandon P; Rowe BH; Vandermeer B; Bain VG
    Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifampicin and pruritus.
    Karas JA; Pillay DG; Sturm AW
    S Afr Med J; 1998 Jul; 88(7):807. PubMed ID: 9698704
    [No Abstract]   [Full Text] [Related]  

  • 28. Outcome of partial internal biliary diversion for intractable pruritus in children with cholestatic liver disease.
    Ramachandran P; Shanmugam NP; Sinani SA; Shanmugam V; Srinivas S; Sathiyasekaran M; Tamilvanan V; Rela M
    Pediatr Surg Int; 2014 Oct; 30(10):1045-9. PubMed ID: 25064227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children.
    Zellos A; Roy A; Schwarz KB
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):787-9. PubMed ID: 20948447
    [No Abstract]   [Full Text] [Related]  

  • 30. [The pathophysiology and treatment of cholestatic pruritus].
    Wolfhagen FH; Engelkens HJ; van Buuren HR
    Ned Tijdschr Geneeskd; 1998 Mar; 142(13):688-92. PubMed ID: 9623140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term rifampicin administration in primary biliary cirrhosis.
    Bachs L; Parés A; Elena M; Piera C; Rodés J
    Gastroenterology; 1992 Jun; 102(6):2077-80. PubMed ID: 1587427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
    Baumann U; Sturm E; Lacaille F; Gonzalès E; Arnell H; Fischler B; Jørgensen MH; Thompson RJ; Mattsson JP; Ekelund M; Lindström E; Gillberg PG; Torfgård K; Soni PN
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101751. PubMed ID: 34182185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of pruritus of primary biliary cirrhosis with rifampin.
    Podesta A; Lopez P; Terg R; Villamil F; Flores D; Mastai R; Udaondo CB; Companc JP
    Dig Dis Sci; 1991 Feb; 36(2):216-20. PubMed ID: 1988266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of intravenous naloxone in severe pruritus of acute cholestasis.
    Joshi GG; Thakur BS; Sircar S; Namdeo A; Jain AK
    Indian J Gastroenterol; 2009; 28(5):180-2. PubMed ID: 20107967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and treatment of pruritus in cholestasis.
    Kremer AE; Beuers U; Oude-Elferink RP; Pusl T
    Drugs; 2008; 68(15):2163-82. PubMed ID: 18840005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propofol and cholestatic pruritus.
    Borgeat A; Wilder-Smith O; Mentha G; Huber O
    Am J Gastroenterol; 1992 May; 87(5):672-4. PubMed ID: 1595661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety considerations for the management of cholestatic itch.
    Trivella J; Levy C
    Expert Opin Drug Saf; 2021 Aug; 20(8):915-924. PubMed ID: 33836644
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of Butorphanol as Treatment for Cholestatic Itch.
    Golpanian RS; Yosipovitch G; Levy C
    Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on the physiopathology and therapeutic management of cholestatic pruritus in children.
    Thébaut A; Debray D; Gonzales E
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):103-109. PubMed ID: 29031874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pruritus in liver disease. Pathogenesis and treatment].
    Kremer AE; Maillette de Buy Wenniger L; Oude Elferink RP; Beuers U
    Ned Tijdschr Geneeskd; 2011; 155(52):A4045. PubMed ID: 22217242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.